This article has been updated to clarify that Roche's HPV assay is the only one on the market with an FDA-approved primary screening indication, and not the only FDA-approved HPV test on the market.

NEW YORK (GenomeWeb) – The US Preventative Services Task Force has issued draft recommendations proposing that women in their 20s be screened for cervical cancer every three years with cervical cytology alone. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.